primary HCC tissue; paired adjacent non-tumorous liver tissue
SK-Hep-1; HepG2; LO2; 293T
-
NF-kappaB (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (promotes)
RNA-seq; RT-qPCR; Sanger Sequencing; RNA Pull-Down; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Western Blot; FISH / smFISH; IF (Immunofluorescence); Transfection; CCK8; Wound Healing Assay; Transwell Assay; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Bioinformatics Analysis; Clinical Sample Validation
circLIFR (hsa_circ_0072309) is down-regulated in HCC tissues. Functional assays show circLIFR overexpression promotes HCC cell proliferation, migration/invasion, cell cycle progression and inhibits apoptosis, mechanistically by binding TBK1 and enhancing NF-kappaB activity with increased downstream gene expression (e.g., MMP13, MMP3, VEGF, MAPK).
0.8072
Downregulation of circLIFR exerts cancer-promoting effects on hepatocellular carcinoma in vitro.
combined biological and clinical study